Oncology & Cancer
Sleeping sickness drug may provide long-term protection against skin cancer
An antiparasitic agent used to treat African sleeping sickness might someday be used to prevent nonmelanoma skin cancers. Researchers found that DFMO, or α-difluoromethylornithine, still appeared to protect against nonmelanoma ...
Oct 24, 2011
0
0